Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Return on Assets (2016 - 2025)

Abeona Therapeutics (ABEO) has 15 years of Return on Assets data on record, last reported at 0.41% in Q3 2025.

  • For Q3 2025, Return on Assets rose 20.0% year-over-year to 0.41%; the TTM value through Sep 2025 reached 0.41%, up 20.0%, while the annual FY2024 figure was 0.79%, 5.0% down from the prior year.
  • Return on Assets reached 0.41% in Q3 2025 per ABEO's latest filing, up from 0.54% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.31% in Q1 2021 and bottomed at 2.04% in Q3 2022.
  • Average Return on Assets over 5 years is 0.85%, with a median of 0.73% recorded in 2023.
  • Peak YoY movement for Return on Assets: plummeted -149bps in 2022, then soared 125bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.94% in 2021, then dropped by -7bps to 1.0% in 2022, then increased by 27bps to 0.73% in 2023, then rose by 2bps to 0.72% in 2024, then soared by 43bps to 0.41% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.41% in Q3 2025, 0.54% in Q2 2025, and 0.84% in Q1 2025.